Name Dana Sleiman
Title MD
Primary Specialty Endocrinology, Diabetes and Osteoporosis Consultant
Languages Arabic, English & French
Contact Details
Email [email protected]
Phone +974 4400 4400

Social Media

Scope of Practice

Highlights

Academic Achievements:

0 +
Conferences
0 +
Research
0 +
Pro Courses

Community Outreach Activities/Achievements:

Health Care Profession Achievements:

Experience & Education

Certifications & Memberships

Publications

Most Recent

See more publications

  1. Multinational open label randomized active controlled 3 arm parallel groups 24 weeks’ study comparing combination of glimepiride and metformin versus glimepiride and metformin alone in patients with type two diabetes. Research co-investigator 2013 {Sponsored by Sanofi- Aventis}
  2. Diabetes: From Etiology to Complications Data Collector & Analyst - {Prepared for Ministry of Social Affairs Workshop} 2013
  3. GLP 1 and Macrovascular Complications Data Collector & Analyst - 2012 {Prepared for the Journal of Diabetes and Metabolism}